An Improved Peer-Review System to Compensate for Scientific Misconduct in Health-Sensitive Topics

Affiliations

¹ R&C Research, Bovezzo, Italy.
² Fondazione Achille Sclavo Onlus, Siena, Italy.
³ Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), Padova University, Padova, Italy.
⁴ Istituto Superiore di Sanità, Rome, Italy.
⁵ Clinical Pharmacy Unit, School of Pharmacy, Jimma University, Jimma, Ethiopia.
⁶ Delle Medical Center, Rome, Italy.
⁷ Polyclinic University Hospital, Palermo, Italy.

Alessandro Rovetta et al. Public Health Rev. 2023.

. 2023 Jun 2:44:1605601.

doi: 10.3389/phrs.2023.1605601. eCollection 2023.

¹ R&C Research, Bovezzo, Italy.
² Fondazione Achille Sclavo Onlus, Siena, Italy.
³ Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), Padova University, Padova, Italy.
⁴ Istituto Superiore di Sanità, Rome, Italy.
⁵ Clinical Pharmacy Unit, School of Pharmacy, Jimma University, Jimma, Ethiopia.
⁶ Delle Medical Center, Rome, Italy.
⁷ Polyclinic University Hospital, Palermo, Italy.

No abstract available

Keywords: BIV1-CovIran; ethics education in medicine and public health; misconduct; peer review crisis; public health.

Conflict of interest statement

The authors declare that they do not have any conflicts of interest.

A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran.
Ghafari M, Hosseinpour S, Rezaee-Zavareh MS, Dascalu S, Rostamian S, Aramesh K, Madani K, Kordasti S. Ghafari M, et al. BMC Med. 2023 Nov 13;21(1):429. doi: 10.1186/s12916-023-03127-8. BMC Med. 2023. PMID: 37953291 Free PMC article.

1. Mohraz M, Salehi M, Tabarsi P, Abbasi-Kangevari M, Ghamari SH, Ghasemi E, et al. Safety and Immunogenicity of an Inactivated Virus Particle Vaccine for SARS-CoV-2, BIV1-CovIran: Findings from Double-Blind, Randomised, Placebo-Controlled, Phase I and II Clinical Trials Among Healthy Adults. BMJ Open (2022) 12(4):e056872. Erratum in: BMJ Open 2022 Nov 7;12(11):e056872corr1 PMID: 35396297; PMCID: PMC8995575. 10.1136/bmjopen-2021-056872 - DOI - PMC - PubMed
1. Peer Review History. Peer Review History of “Safety and Immunogenicity of a Novel Inactivated Virus Particle Vaccine for SARS-CoV-2, BIV1-CovIran: Findings from Double-Blind, Randomised, Placebo-Controlled, Phase I and II Clinical Trials Among Healthy Adults”. (2022). Available at: https://bmjopen.bmj.com/content/bmjopen/12/4/e056872.reviewer-comments.pdf (accessed Nov 13, 2022). - PubMed
1. Torbati Y. Amid Covid Surge, Iran Cut Corners to Approve Yet-Unproven Vaccine (2022). Available at: https://www.washingtonpost.com/world/2022/08/20/iran-covid-vaccine-appro... (accessed Nov 13, 2022).
1. Bekelman JE, Li Y, Gross CP. Scope and Impact of Financial Conflicts of Interest in Biomedical Research: a Systematic Review. JAMA (2003) 289(4):454–65. PMID: 12533125. 10.1001/jama.289.4.454 - DOI - PubMed
1. Greenland S. Accounting for Uncertainty about Investigator Bias: Disclosure Is Informative. J Epidemiol Community Health (2009) 63(8):593–8. PMID: 19596837. 10.1136/jech.2008.084913 - DOI - PubMed